{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-111285","form_type":"8-K","ticker":"TELA","cik":"0001561921","company_name":"TELA Bio, Inc.","filed_at":"2025-11-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.745194+00:00","generated_at":"2026-05-16T20:21:04.120387+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"TELA Bio Q3 revenue $20.7M (+9% YoY); upsizes credit facility to $70M with Perceptive","bullets":["Q3 revenue $20.7M (+9% YoY); net loss $8.6M vs $10.4M year ago; operating loss $7.6M.","Full-year 2025 revenue guidance revised to at least 16% growth over 2024.","Closed $70M credit facility from Perceptive Advisors: $60M initial draw, $10M accordion; interest rate 7.85%+greater of Term SOFR or 4.25%, interest-only to Nov 2030.","Appointed Betty Jo Rocchio and Bill Plovanic to the Board of Directors."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-111285","json":"https://secwatch.observer/filing/0001104659-25-111285.json","markdown":"https://secwatch.observer/filing/0001104659-25-111285.md","text":"https://secwatch.observer/filing/0001104659-25-111285.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1561921/000110465925111285/0001104659-25-111285-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1561921/000110465925111285/tm2531116d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T20:21:04.120387+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}